FILE:ABT/ABT-8K-20070305164614.txt.gz
EVENTS:	Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
TEXT:
ITEM: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
 
 
WASHINGTON, D.C. 20549
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
 
FORM 8-K
CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
February
, 2007
28
(Exact name of registrant as specified in its charter)
ABBOTT LABORATORIES
 
100 Abbott Park Road
Abbott Park, Illinois 60064-6400
(Address of principal executive offices)(Zip Code)
Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
                   
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
                   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
                   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
                   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
Item 5.02  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 28, 2007, Miles D. White, Chairman and Chief Executive Officer of Abbott Laboratories, Richard A. Gonzalez, Abbott's President and Chief Operating Officer, and Thomas C. Freyman, Abbott's Executive Vice President, Finance and Chief Financial Officer voluntarily terminated their Change in Control Agreements.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 


